A Phase 1, Double-Blind Randomized, Placebo-Controlled, Sequential, Multiple Ascending-Dose, Pharmacokinetic and Pharmacodynamic Single-Center Study to Evaluate the Use of SYR-472 in Healthy Subjects

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.